MARKET

CMOPF

CMOPF

Cosmo Pharmaceuticals Nv
OTCPK
73.00
NaN%
Closed 09:30 03/19 EDT
OPEN
--
PREV CLOSE
73.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
76.00
52 WEEK LOW
73.00
MARKET CAP
1.19B
P/E (TTM)
15.72
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CMOPF last week (0310-0314)?
Weekly Report · 3d ago
Weekly Report: what happened at CMOPF last week (0303-0307)?
Weekly Report · 03/10 10:31
Cosmo Pharmaceuticals N.V. reports FY results
Seeking Alpha · 03/06 21:53
Cosmo Pharmaceuticals Delivers Record 2024 Results - Completes Phase III Enrollment for Androgenetic Alopecia in Males - Proposes Increased Dividend of 2.05 per share - Reinforcing Shareholder Value and Growth Momentum into 2025
Newsfile · 03/06 06:01
Weekly Report: what happened at CMOPF last week (0224-0228)?
Weekly Report · 03/03 10:30
Weekly Report: what happened at CMOPF last week (0217-0221)?
Weekly Report · 02/24 10:30
Weekly Report: what happened at CMOPF last week (0210-0214)?
Weekly Report · 02/17 10:28
Cosmo to Host Investor Day on April 9, 2025
Newsfile · 02/12 06:01
More
About CMOPF
Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases and dermatology. Its development pipeline is focused on Breezula (clascoterone), GI Genius, Methylene blue MMX, Aemcolo, CB-03-10, CB-01-33 (colesevelam), and CB-01-35. The Company's developed products include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travelers’ diarrhea (TD), Methylene Blue MMX, which is a new diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy and Winlevi for the treatment of acne. Its therapeutic focus is on the oral and endoscopic treatment of colon diseases.

Webull offers Cosmo Pharmaceuticals NV stock information, including OTCPK: CMOPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMOPF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMOPF stock methods without spending real money on the virtual paper trading platform.